Abbvie pushes jumbo deal through rates vol
US pharmaceutical company Abbvie hit the corporate new issue market on Monday, making its euro debut as a volatile backdrop in government bonds began to filter into the corporate bond market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: